Definitive Healthcare Corp. (NASDAQ:DH) Q4 2023 Earnings Conference Call February 28, 2024 5:00 PM ET

Company Participants

Matt Ruderman - Chief Legal Officer

Jason Krantz - Founder and Executive Chairman and Interim CEO

Richard Booth - CFO

Conference Call Participants

Stephanie Davis - Barclays

Craig Hettenbach - Morgan Stanley

Craig Jones - Stifel

Matthew Shea - Needham & Company

Allen Lutz - Bank of America

Jared Haase - William Blair

Johnathan McCary - Raymond James

George Hill - Deutsche Bank

Operator

Welcome to Definitive Healthcare's Q4 2023 Earnings Call. Our host for today's call is Jason Krantz. [Operator Instructions]. I would now like to turn the call over to your host, Mr. Krantz, you may begin.

Matt Ruderman

Good afternoon, and thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Jason Krantz, Founder, Executive Chairman and Interim CEO; and Rick Booth, our CFO.

During this call, we will make forward-looking statements, including, but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our health care commercial intelligence solutions, our competitive position, customer behaviors and use of our solutions, our financial guidance, our planned investments, generating value for our customers and shareholders and the anticipated impacts of global macroeconomic conditions on our business results and clients and on the health care industry generally.

Any forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the Risk Factors section and elsewhere in our filings with the SEC. Actual results may differ materially from any forward-looking statements. The company undertakes no obligation to revise or update any forward-looking statements to reflect events that may arise after this conference call, except as required by law.

For more information, please refer to the cautionary statement included in the earnings release that we have just posted in the Investor Relations portion of our website. Additionally, we will discuss non-GAAP financial measures on this conference call. Please refer to the tables in our earnings release on the Investor Relations portion of our website for a reconciliation of these measures to their most directly comparable GAAP financial measure.

With that, I'd like to turn the call over to Jason.

Jason Krantz

Thanks, Matt. and thanks to all of you for joining us this afternoon to review definitive Healthcare's Fourth Quarter and Full Year 2023 financial results. Let me begin by saying that I'm excited to be back as definitive Healthcare's CEO on an interim basis. Definitive Healthcare plays a unique and differentiated role in the health care ecosystem, providing thousands of companies with the data and analytics to help them more effectively commercialize in the large and complex health care market. I am energized to once again help Definitive capitalize upon the significant opportunity.